A randomized clinical trial of delirium prevention
Phase of Trial: Phase II
Latest Information Update: 19 Jul 2017
At a glance
- Drugs Suvorexant (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 15 Jul 2017 Status changed from recruiting to completed.
- 24 Nov 2016 Planned number of patients changed from 200 to 70.
- 18 May 2015 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan.